Lannett (LCI) (HGSI) (SWHC) (HSP) (PCG) (IVR) Price Targets Changed

Lannett Company Incorporated (NYSE: LCI), Human Genome Sciences (NASDAQ: HGSI), Smith & Wesson (NASDAQ: SWHC), Hospira, Inc. (NYSE: HSP), PG&E Co. (NYSE: PCG) and Invesco Mortgage Capital Inc (NYSE: IVR) had price targets adjusted by analysts.

Lannett Company Incorporated (LCI) had its price target lowered by Oppenheimer from $7.00 to $6.00. They have an “Outperform” rating on the company.

Human Genome Sciences (HGSI) had its price target lowered by RBC Dain Rauscher from $32.00 to $25.00. They have an “Outperform” rating on the company.

Smith & Wesson (SWHC) had its price target lowered by Wedbush from $5.00 to $4.00.

Hospira, Inc. (HSP) had its price target lowered by JPMorgan Chase & Co. (NYSE:JPM) to $60.00.

PG&E Co. (PCG) had its price target raised by Jefferies (NYSE:JEF) from $44.50 to $45.50. They have a “Hold” rating on the company.

Invesco Mortgage Capital Inc. (IVR) had its price target lowered by Wunderlich from $19.00 to $17.00.